New solid forms of the anti-HIV drug etravirine: Salts, cocrystals, and solubility

Crystal Growth and Design

Volumn 13, Issue 8, 2013, Pages 3681-3690

  Rajput, Lalit ^a   Sanphui, Palash ^a   Desiraju, Gautam R ^a  

^a INDIAN INSTITUTE OF SCIENCE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

1 ,3 ,5-BENZENETRICARBOXYLIC ACID; ACTIVE PHARMACEUTICAL INGREDIENTS; AQUEOUS SOLUBILITY; CONFORMATIONAL FLEXIBILITY; ETHANOL WATER MIXTURES; SLURRY EXPERIMENT; SOLUBILITY BEHAVIOR; STRUCTURE PROPERTY RELATIONSHIPS;

CONFORMATIONS; SALTS; SULFUR COMPOUNDS;

SOLUBILITY;

EID: 84881406205     PISSN: 15287483     EISSN: 15287505     Source Type: Journal    
DOI: 10.1021/cg4007058     Document Type: Article

References (66)

1. Desiraju, G. R. Crystal Engineering: The Design of Organic Solids; Elsevier: Amsterdam, 1989; pp 175-198.
2. Desiraju, G. R. Angew. Chem., Int. Ed. 1995, 34, 2311-2327
3. Making Crystals by Design: From Molecules to Molecular Materials, Methods, Techniques, Applications; Grepioni, F.; Braga, D.; Eds.; Wiley-VCH: Weinheim, Germany, 2007; pp 209-240.
4. Generally Regarded as Safe chemicals by the U.S. FDA. http://www.fda.gov/Food/IngredientsPackagingLabeling/FoodAdditivesIngredients/ ucm091048.htm (accessed March 24, 2013).
5. Grant, D. J. W.; Brittain, H. G. Solubility of Pharmaceutical Solids. In Physical Characterization of Pharmaceutical Solids; Brittain, H. G., Ed.; Marcel Dekker, Inc.: New York, 1995; pp 321-386.
6. Remenar, J. F.; Morissette, S. L.; Peterson, M. L.; Moulton, B.; Mac-Phee, J. M.; Guzmán, H.; Almarsson, Ö. J. Am. Chem. Soc. 2003, 125, 8456-8457
7. Huang, L. F.; Tong, W. Q. Adv. Drug Delivery Rev. 2004, 56, 321-334
8. Trask, A. V.; Motherwell, W. D. S.; Jones, W. Cryst. Growth Des. 2005, 5, 1013-1021
9. Jones, W.; Motherwell, W. D. S.; Trask, A. V. MRS Bull. 2006, 31, 875-879
10. Karki, S.; Friscic, T.; Fabian, L.; Laity, P. R.; Day, G. M.; Jones, W. Adv. Mater. 2009, 21, 3905-3909
11. Schultheiss, N.; Newman, A. Cryst. Growth Des. 2009, 9, 2950-2967
12. Brits, M.; Liebenberg, W.; De Villiers, M. M. J. Pharm. Sci. 2010, 99, 1138-1151
13. Cheney, M. L.; Shan, N.; Healey, E. R.; Hanna, M.; Wojtas, L.; Zaworotko, M. J.; Sava, V.; Song, S.; Sanchez-Ramos, J. R. Cryst. Growth Des. 2010, 10, 394-405
14. Smith, A. J.; Kavuru, P.; Wojtas, L.; Zaworotko, M. J.; Shytle, R. D. Mol. Pharmaceutics 2011, 8, 1867-1876
15. Thayer, A. M. Chem. Eng. News 2007, 85, 17-30
16. Prohotsky, D. L.; Zhao, F. J. Pharm. Sci. 2012, 101, 1-6
17. Leuner, C.; Dressman, J. Eur. J. Pharm. Biopharm. 2000, 50, 47-60
18. Anand, P.; Kunnumakkara, A. B.; Newman, R. A.; Aggarwal, B. B. Mol. Pharmaceutics 2007, 4, 807-818
19. Darwish, M. K.; Foad, M. M. Drug Discoveries Ther. 2009, 3, 27-36
20. McNamara, D. P.; Childs, S. L.; Giordano, J.; Iarriccio, A.; Cassidy, J.; Shet, M. S.; Mannion, R.; O'Donnell, E.; Park, A. Pharm. Res. 2006, 23, 1888-1897
21. Good, D. J.; Rodríguez-Hornedo, N. Cryst. Growth Des. 2009, 9, 2252-2264
22. Banerjee, R.; Bhatt, P. M.; Ravindra, N. V.; Desiraju, G. R. Cryst. Growth Des. 2005, 5, 2299-2309
23. Portell, A.; Barbas, R.; Font-Bardia, M.; Dalmases, P.; Prohens, R.; Puigjaner, C. CrystEngComm 2009, 11, 791-795
24. Aitipamula, S.; Wong, A. B. H.; Chowa, P. S.; Tan, R. B. H. CrystEngComm 2012, 14, 8515-8524
25. Bhatt, P. M.; Ravindra, N. V.; Banerjee, R.; Desiraju, G. R. Chem. Commun. (Cambridge, U.K.) 2005, 1073-1075
26. Trask, A. V.; Motherwell, W. D. S.; Jones, W. Int. J. Pharm. 2006, 320, 114-123
27. Aakeröy, C. B.; Forbes, J.; Desper, J. J. Am. Chem. Soc. 2009, 131, 17048-17049
28. Bolla, G.; Sanphui, P.; Nangia, A. Cryst. Growth Des. 2013, 13, 1988-2003
29. Bernstein, J. Conformational Polymorphism. In Organic Solid State Chemistry; Desiraju, G. R., Ed.; Elsevier: Amsterdam, 1987; pp 471-518.
30. Dunitz, J. D. Pure and Applied Chemistry 1991, 63, 177-185
31. Threlfall, T. L. Analyst 1995, 120, 2435-2460
32. Desiraju, G. R. Angew. Chem., Int. Ed. 2007, 46, 8342-8356
33. Griesser, U. J.; Jetti, R. K. R.; Haddow, M. F.; Brehmer, T.; Apperley, D. C.; King, A.; Harris, R. K. Cryst. Growth Des. 2008, 8, 44-56
34. Castro, R. A. E.; Maria, T. M. R.; Evora, A. O. L.; Feiteira, J. C.; Silva, M. R.; Beja, A. M.; Canotilho, J.; Eusbio, M. E. S. Cryst. Growth Des. 2010, 10, 274-282
35. Bhatt, P. M.; Azim, Y.; Thakur, T. S.; Desiraju, G. R. Cryst. Growth Des. 2009, 9, 951-957
36. Mahapatra, S.; Thakur, T. S.; Joseph, S.; Varughese, S.; Desiraju, G. R. Cryst. Growth Des. 2010, 10, 3191-3202
37. EMEA/CHMP/43952/2008 Assessment Report for Intelence; European Medicines Agency: London, 2008, http://www.ema.europa.eu/docs/en-GB/document-library/EPAR- Public-assessment-report/human/000900/WC500034183.pdf (accessed June 21, 2013).
38. Scholler-Gyure, M.; Kakuda, T. N.; Raoof, A.; De Smedt, G.; Hoetelmans, R. M. Clin Pharmacokinet. 2009, 48, 561-574
39. Sepelj, M.; Leksic, E.; Marinkovic, M.; Krijamanic, I. Polymorphs of Etravirine and Processes for Preparation Thereof. WO 2010/131118 A2, November 2010.
40. Sansone, M. F.; Baert, L. E. C.; Tawa, M.; Remenar, J. F. Co-crystal of Etravirine and Nicotinamide. US2012028998 A1, February 2012.
41. Amidon, G. L.; Lennernas, H.; Shah, V. P.; Crison, J. R. Pharm. Res. 1995, 12, 413-420
42. Benet, L. Z.; Amidon, G. L.; Barends, D. M.; Lennernäs, H.; Polli, J. E.; Shah, V. P.; Stavchansky, S. A.; Yu, L. X. Pharm. Res. 2008, 52, 483-488
43. Das, K.; Clark, A. D., Jr.; Lewi, P. J.; Heeres, J.; De Jonge, M. R.; Koymans, L. M.; Vinkers, H. M.; Daeyaert, F.; Ludovici, D. W.; Kukla, M. J.; De Corte, B.; Kavash, R. W.; Ho, C. Y.; Ye, H.; Lichtenstein, M. A.; Andries, K.; Pauwels, R.; De Bethune, M. P.; Boyer, P. L.; Clark, P.; Hughes, S. H.; Janssen, P. A.; Arnold, E. J. Med. Chem. 2004, 47, 2550-2560
44. Lapadula, G.; Soria, A.; Gori, A. Clin. Med.: Ther. 2009, 1, 483-494
45. Lansdon, E. B.; Brendza, K. M.; Hung, M.; Wang, R.; Mukund, S.; Jin, D.; Birkus, G.; Kutty, N.; Liu, X. J. Med. Chem. 2010, 53, 4295-4299
46. de Bethune, M.-P. Antiviral Res. 2010, 85, 75-90
47. Calin, R.; Paris, L.; Simon, A.; Peytavin, G.; Wirden, M.; Schneider, L.; Valantin, M.-A.; Tubiana, R.; Agher, R.; Katlama, C. Antiviral Ther. 2012, 17, 1601-1604
48. Agneskog, E.; Nowak, P.; Kaellander, C. F. R.; Soennerborg, A. J. Med. Virol. 2013, 85, 703-708
49. Guidance for Industry: Regulatory Classification of Pharmaceutical Co-Crystals; U.S. Department of Health and Human Services, FDA, Center for Drug Evaluation and Research (CDER): Silver Spring, MD, 2013, (http://www.fda.gov/ downloads/Drugs/Guidances/UCM281764.pdf).
50. Aitipamula, S.; Banerjee, R.; Bansal, A. K.; Biradha, K.; Cheney, M. L.; Choudhury, A. R.; Desiraju, G. R.; Dikundwar, A. G.; Dubey, R.; Duggirala, N.; Ghogale, P. P.; Ghosh, S.; Goswami, P. K.; Goud, N. R.; Jetti, R. K. R.; Karpinski, P.; Kaushik, P.; Kumar, D.; Kumar, V.; Moulton, B.; Mukherjee, A.; Mukherjee, G.; Myerson, A. S.; Puri, V.; Ramanan, A.; Rajamannar, T.; Reddy, C. M.; Rodriguez-Hornedo, N.; Rogers, R. D.; Row, T. N. G.; Sanphui, P.; Shan, N.; Shete, G.; Singh, A.; Sun, C. C.; Swift, J. A.; Thaimattam, R.; Thakur, T. S.; Thaper, R. K.; Thomas, S. P.; Tothadi, S.; Vangala, V. R.; Vishweshwar, P.; Weyna, D. R.; Zaworotko, M. J. Cryst. Growth Des. 2012, 12, 2147-2152
51. Remenar, J. F.; Peterson, M. L.; Stephens, P. W.; Zhang, Z.; Zimenkov, Y.; Hickey, M. B. Mol. Pharmaceutics 2007, 4, 386-400
52. Karki, S.; Friščić, T.; Fábián, T.; Jones, W. CrystEngComm 2010, 12, 4038-4041
53. André, V.; Fernandes, A.; Santos, P. P.; Duarte, M. T. Cryst. Growth Des. 2011, 11, 2325-2334
54. Bauer, J.; Spanton, S.; Henry, R.; Quick, J.; Dziki, W.; Porter, W.; Morris, J. Pharm. Res. 2001, 18, 859-866
55. Sanphui, P.; Bolla, G.; Nangia, A. Cryst. Growth Des. 2012, 12, 2023-2026
56. Friščić, T.; Childs, S. L.; Rizvi, S. A. A.; Jones, W. CrystEngComm 2009, 11, 418-426
57. Alhalaweh, A.; Velaga, S. P. Cryst. Growth Des. 2010, 10, 3302-3305
58. Rodríguez-Hornedo, N.; Nehm, S. J.; Seefeldt, K. F.; Pagán-Torres, Y.; Falkiewicz, C. J. Mol. Pharmaceutics 2006, 3, 362-367
59. Goud, N. R.; Gangavaram, S.; Suresh, K.; Pal, S.; Manjunatha, N. G.; Nambiar, S. J. Pharm. Sci. 2012, 101, 664-680
60. Rigaku Mercury375R/M CCD. Crystal Clear-SM Expert 2.0 rc14; Rigaku Corporation: Tokyo, Japan, 2009.
61. Sheldrick, G. M. Acta Crystallogr. 2008, A64, 112-122
62. Farrugia, L. J. J. Appl. Crystallogr. 1999, 32, 837-838
63. Spek, A. L. PLANTON, A Multipurpose Crystallographic Tool; Utrecht University: Utrecht, The Netherlands, 2002
64. Spek, A. L. Single crystal structure validation with the program PLATON J. Appl. Crystallogr. 2003, 36, 7-13
65. Materials Studio, version 6.0; Accelrys Corporation: San Diego, CA, 2011.
66. Glomme, A.; Marz, J.; Dressman, J. B. J. Pharm. Sci. 2005, 94, 1-16